R&D

Advanced biopharmaceutical development company

Mitochondria

Mitochondria are known as one of the organelles in the cell that synthesize the energy needed within the cell. Mitochondria have recently been known as an important organ for maintaining a healthy life as the key to aging and disease.

Mitochondria are intracellular organelles that have their own DNA, and there is no mechanism for repairing damage, so damage caused by reactive oxygen species (ROS) accumulates and causes various diseases and aging.

Our company has secured technologies related to the control (separation, processing, storage, etc.) of mitochondria in these cells as core technologies, and we are accelerating the development of advanced biopharmaceuticals and advanced regenerative medicine using this.

Advanced Biopharmaceuticals

MITO ADD™

MITO ADD, a mitochondrial treatment under development, is an advanced biopharmaceutical to treat tendinopathy, one of the intractable diseases. (Selected as national project in 2022)

It is a new drug that treats incurable diseases by injecting healthy mitochondria into the affected area and using mitochondria inflammatory response control and cell and tissue regeneration.